Episode

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Podcast

Few & Far Between: How Biotech Gets Built

Published

Apr 29, 2025

Duration seconds

3046

Processing state

not_requested

Canonical source

https://few-far-between-conversations-about-rare-disease-research.castos.com/episodes/episode-53-frank-david-founder-and-managing-director-pharmagellan

Audio

https://dts.podtrac.com/redirect.mp3/episodes.castos.com/6026d270a471b8-76273800/2021898/c1e-x878rs9d9mzi0pvxx-okmpk0m9f5rp-3afyvc.mp3

JSON

/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-53-frank-david-founder-and-managing-director-pharmagellan

Markdown

/podcast/few-far-between-how-biotech-gets-built-4067896/episode-53-frank-david-founder-and-managing-director-pharmagellan.md

Actions

• POST https://stenobird.com/v1/public/podcasts/few-far-between-how-biotech-gets-built-4067896/episodes/episode-53-frank-david-founder-and-managing-director-pharmagellan/transcription-requests
  Idempotently request low-priority transcript generation for this episode.
• GET https://stenobird.com/podcast/few-far-between-how-biotech-gets-built-4067896/episode-53-frank-david-founder-and-managing-director-pharmagellan.md
  Read the agent-friendly Markdown representation of this episode resource.

Summary

How do mission, vision, and data analysis fit into today's biotech goals? Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan to the podcast. Tune in as we explore R&D strategy, de-risking tactics, and how to think about valuation. Listen in to the latest episode of the Biorasi Few & Far Between podcast today!